Melatonin and Leishmania amazonensis Infection Altered miR-294, miR-30e, and miR-302d Impacting on Tnf, Mcp-1, and Nos2 Expression

Juliane Cristina Ribeiro Fernandes,Juliana Ide Aoki,Stephanie Maia Acuña,Ricardo Andrade Zampieri,Regina P. Markus,Lucile Maria Floeter-Winter,Sandra Marcia Muxel
DOI: https://doi.org/10.3389/fcimb.2019.00060
IF: 6.073
2019-03-20
Frontiers in Cellular and Infection Microbiology
Abstract:Leishmaniases are neglected diseases that cause a large spectrum of clinical manifestations, from cutaneous to visceral lesions. The initial steps of the inflammatory response involve the phagocytosis of <i>Leishmania</i> and the parasite replication inside the macrophage phagolysosome. Melatonin, the darkness-signaling hormone, is involved in modulation of macrophage activation during infectious diseases, controlling the inflammatory response against parasites. In this work, we showed that exogenous melatonin treatment of BALB/c macrophages reduced <i>Leishmania amazonensis</i> infection and modulated host microRNA (miRNA) expression profile, as well as cytokine production such as IL-6, MCP-1/CCL2, and, RANTES/CCL9. The role of one of the regulated miRNA (miR-294-3p) in <i>L. amazonensis</i> BALB/c infection was confirmed with miRNA inhibition assays, which led to increased expression levels of <i>Tnf</i> and <i>Mcp-</i>1/<i>Ccl2</i> and diminished infectivity. Additionally, melatonin treatment or miR-30e-5p and miR-302d-3p inhibition increased nitric oxide synthase 2 (<i>Nos2</i>) mRNA expression levels and nitric oxide (NO) production, altering the macrophage activation state and reducing infection. Altogether, these data demonstrated the impact of melatonin treatment on the miRNA profile of BALB/c macrophage infected with <i>L. amazonensis</i> defining the infection outcome.
immunology,microbiology
What problem does this paper attempt to address?